LRC opens mild stimulation fertility research centre

New Bangkok facility pioneers gentle, safer fertility treatments for women of advanced maternal age through research, innovation, and global collaboration.

Bangkok, August 19, 2025 — Jointly established by Rhea Medical Group and Thailand’s LRC Fertility Center, the LRC Mild Stimulation Research Center was officially inaugurated in Bangkok on August 16, 2025. The centre is dedicated to in-depth research, protocol optimisation, and clinical application of mild stimulation technology, with the mission of creating a safer, more patient-friendly, and more effective fertility pathway—particularly for families worldwide facing the challenges of advanced maternal age.

Breaking the Advanced Age Dilemma: The Core Mission of the Research Center

The establishment of the LRC Mild Stimulation Research Center stems from a deep understanding of the fertility needs of women of advanced maternal age. As a pioneer of the “mild stimulation” approach in Thailand, the centre adopts scientific and gentle ovarian stimulation protocols designed to minimise the physical burden and potential risks of medication for older women. With women’s health and safety as its top priority, the centre aims to provide a fertility journey that is closer to nature and more respectful of individual choices.

Core Philosophy: Listening to the Body, Letting Life Begin Gently

Traditional high-intensity treatments, while offering hope, often come with significant physical burdens and emotional stress. To make every step of assisted reproduction more in tune with the body’s natural rhythm, more respectful of its wisdom, and more caring toward the emotional journey, the LRC Mild Stimulation Research Center has chosen a different path:

• “Less is More” — Achieving higher-quality eggs through lower medication doses and gentler interventions.
• “Listening to the Body” — Recognising every woman as a unique individual and developing highly personalised treatment protocols.
• “Protecting Safety and Dignity” — Prioritising patient safety and dignity by significantly reducing risks such as OHSS.
• “Caring from Within” — Gentle treatments that not only ease the body’s burden but also comfort the heart and mind.

Professional Empowerment: The Key to Overcoming Fertility Challenges in Advanced Maternal Age

The establishment of the centre marks a new milestone in LRC’s professional expertise in fertility care for women of advanced maternal age. The centre is committed to continuously enhancing its technical capabilities, particularly in the critical stage of blastocyst development for older patients:

• Top-tier Blastocyst Culture — With state-of-the-art embryology labs and advanced blastocyst culture techniques, the centre maximises the potential and quality of embryos derived from the smaller number of eggs typically obtained through mild stimulation, directly supporting higher success rates.
• Personalised Protocol Design — Led by Dr Somphoch, an expert in advanced maternal age and diminished ovarian reserve, and Dr Kittiya, a specialist in individualised treatment planning, each patient receives a carefully tailored, gentle, and effective ovarian stimulation protocol.
• Maximising Embryo Potential — Embryo specialists at the centre focus on optimising embryo development to ensure each embryo achieves its best possible growth.
• Global Research Network Support — Fully integrated into Rhea Group’s international research network and strategically collaborating with 28 top-tier laboratories worldwide, the centre continuously refines technical protocols and translates cutting-edge research into clinical practice.

Looking Ahead: Setting a New Benchmark for Gentle Fertility Care

The LRC Mild Stimulation Research Center is not only dedicated to systematically optimising and promoting mild stimulation techniques to fill a gap in the Thai market but also looks beyond borders—striving to become a global leader in research, innovation, and clinical application of mild stimulation-assisted reproductive technology. By continuously exploring technological frontiers and expanding international collaboration, the centre aims to work hand in hand with colleagues worldwide to build a brighter future for fertility.